Bipartite interaction between neurofibromatosis type I protein (neurofibromin) and syndecan transmembrane heparan sulfate proteoglycans.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
  • Author(s): Hsueh YP;Hsueh YP; Roberts AM; Volta M; Sheng M; Roberts RG
  • Source:
    The Journal of neuroscience : the official journal of the Society for Neuroscience [J Neurosci] 2001 Jun 01; Vol. 21 (11), pp. 3764-70.
  • Publication Type:
    Journal Article; Research Support, Non-U.S. Gov't
  • Language:
    English
  • Additional Information
    • Source:
      Publisher: Society for Neuroscience Country of Publication: United States NLM ID: 8102140 Publication Model: Print Cited Medium: Internet ISSN: 1529-2401 (Electronic) Linking ISSN: 02706474 NLM ISO Abbreviation: J Neurosci Subsets: MEDLINE
    • Publication Information:
      Publication: Washington, DC : Society for Neuroscience
      Original Publication: [Baltimore, Md.] : The Society, c1981-
    • Subject Terms:
    • Abstract:
      The neurofibromatosis type 1 (NF1) gene encodes a large tumor suppressor protein (neurofibromin). Although it is known to possess Ras GTPase-activating protein (GAP) activity, the cellular role of neurofibromin remains unclear. Here we used yeast two-hybrid screening to identify neurofibromin-interacting proteins. Syndecan-2, a transmembrane heparan sulfate proteoglycan (HSPG), was isolated as a binding partner for two distinct regions of the neurofibromin protein. We subsequently found that neurofibromin can bind all four mammalian syndecans. NF1 interaction requires the transmembrane domain and a membrane-proximal region of the cytoplasmic tail of syndecan, but not the C terminus of syndecan known to bind to CASK, a membrane-associated guanylate kinase (MAGUK). Neurofibromin, syndecans, and CASK have overlapping subcellular distributions in axons and synapses of neurons, as shown by biochemical fractionation and immunostaining. Moreover, neurofibromin exists in a complex with syndecan and CASK in vivo, as evidenced by their coimmunoprecipitation from rat brain. Our findings suggest that interaction with different members of the syndecan family may be a mechanism for localizing neurofibromin to specialized domains of the plasma membrane.
    • Comments:
      Erratum in: J Neurosci. 2017 Feb 1;37(5):1374. (PMID: 28148807)
    • References:
      Nat Genet. 1994 Jul;7(3):353-61. (PMID: 7920653)
      Proc Natl Acad Sci U S A. 1997 Dec 9;94(25):13683-8. (PMID: 9391086)
      J Neurosci. 1993 Apr;13(4):1588-600. (PMID: 8463837)
      Cell. 1995 Nov 3;83(3):357-60. (PMID: 8521464)
      Biochem J. 1997 Oct 1;327 ( Pt 1):1-16. (PMID: 9355727)
      J Neurosci. 1999 Sep 1;19(17):7415-25. (PMID: 10460248)
      J Cell Biol. 1998 Jul 13;142(1):139-51. (PMID: 9660869)
      Curr Opin Cell Biol. 1997 Dec;9(6):853-9. (PMID: 9425351)
      Genes Dev. 1994 May 1;8(9):1019-29. (PMID: 7926784)
      J Cell Biol. 1998 Jul 13;142(1):129-38. (PMID: 9660868)
      J Cell Biol. 1983 May;96(5):1374-88. (PMID: 6404912)
      Cell. 1990 Nov 16;63(4):843-9. (PMID: 2121370)
      Cell. 1998 Sep 18;94(6):761-71. (PMID: 9753323)
      Cell. 1998 Sep 18;94(6):691-4. (PMID: 9753315)
      Science. 1997 May 2;276(5313):795-8. (PMID: 9115204)
      Cell. 1998 Sep 18;94(6):773-82. (PMID: 9753324)
      J Biol Chem. 1995 Nov 3;270(44):26404-10. (PMID: 7592855)
      Methods Enzymol. 1998;293:104-22. (PMID: 9711605)
      Annu Rev Cell Biol. 1992;8:365-93. (PMID: 1335744)
      Nature. 2000 Apr 13;404(6779):725-8. (PMID: 10783877)
      FASEB J. 1993 Aug;7(11):1023-30. (PMID: 8370471)
      Nature. 2000 Feb 24;403(6772):895-8. (PMID: 10706287)
      Cell. 1990 Nov 16;63(4):851-9. (PMID: 2121371)
      Science. 1999 Dec 10;286(5447):2176-9. (PMID: 10591653)
      Science. 1999 Dec 10;286(5447):2172-6. (PMID: 10591652)
      Annu Rev Neurosci. 2001;24:1-29. (PMID: 11283303)
      Neuron. 1992 Mar;8(3):415-28. (PMID: 1550670)
      J Cell Biol. 1999 Feb 8;144(3):575-86. (PMID: 9971750)
      Proc Natl Acad Sci U S A. 1992 Feb 1;89(3):932-6. (PMID: 1736308)
    • Grant Information:
      United Kingdom Wellcome Trust
    • Accession Number:
      0 (Heparan Sulfate Proteoglycans)
      0 (Macromolecular Substances)
      0 (Membrane Glycoproteins)
      0 (Nerve Tissue Proteins)
      0 (Neurofibromin 1)
      0 (Proteoglycans)
      0 (SDC2 protein, human)
      0 (SDC3 protein, human)
      0 (Sdc2 protein, rat)
      0 (Sdc3 protein, rat)
      0 (Syndecan-3)
      0 (Syndecans)
      149769-25-5 (Syndecan-2)
      EC 2.7.11.1 (CASK kinases)
      EC 2.7.11.17 (Calcium-Calmodulin-Dependent Protein Kinases)
      EC 2.7.4.4 (Nucleoside-Phosphate Kinase)
      EC 2.7.4.8 (Guanylate Kinases)
    • Publication Date:
      Date Created: 20010523 Date Completed: 20010621 Latest Revision: 20191023
    • Publication Date:
      20231215
    • Accession Number:
      PMC6762697
    • Accession Number:
      11356864